Skip to content
Screener

Achieve Life Sciences ACHV Q3 2025 earnings

Reported November 6, 2025 · Before market open

EPS-$0.28Miss by $0.04
EPS estimate-$0.24

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$10.6M
EPS estimate-$0.20

Financials

Q3 2025

Income statement

See full
Net income-$14.4M-15.4%
EPS (diluted)-$0.28+22.2%

Balance sheet

See full
Cash & equivalents$31.9M+235%
Total debt$1.3M+5,736%
Total equity$33.6M+7.1%
Total assets$52.0M+8.6%

Cash flow

See full
Operating cash flow-$11.3M-9.2%
CapEx$750.0—
Free cash flow-$12.4M—

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$160.98M-1.1%
Enterprise value$130.33M-15.0%

Returns & leverage

See full
Return on equity-161.1%-19.1pp
Debt / equity0×0.0×
Current ratio5.1×-1.6×

FAQ

When did Achieve Life Sciences report Q3 2025 earnings?
Achieve Life Sciences (ACHV) reported Q3 2025 earnings on November 6, 2025 before market open.
What were Achieve Life Sciences's Q3 2025 revenue and EPS?
Achieve Life Sciences reported eps of $-0.28 for Q3 2025.
Did Achieve Life Sciences beat estimates in Q3 2025?
EPS missed the consensus estimate of $-0.24 by $0.04.
How did Achieve Life Sciences's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 22.2% from $-0.36.
Where can I find Achieve Life Sciences's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-268056) and the 10-Q periodic report (0001193125-25-268074) directly on SEC EDGAR. The filing index links above go to sec.gov.